Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

This study has been terminated.
(Problems with IRB)
Milton S. Hershey Medical Center
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jill P. Smith, Penn State University
ClinicalTrials.gov Identifier:
First received: October 30, 2008
Last updated: February 11, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2011
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)